1104 related articles for article (PubMed ID: 19782780)
21. Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor beta1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation.
Lee MH; Javed A; Kim HJ; Shin HI; Gutierrez S; Choi JY; Rosen V; Stein JL; van Wijnen AJ; Stein GS; Lian JB; Ryoo HM
J Cell Biochem; 1999 Apr; 73(1):114-25. PubMed ID: 10088730
[TBL] [Abstract][Full Text] [Related]
22. Enhanced expression of the inorganic phosphate transporter Pit-1 is involved in BMP-2-induced matrix mineralization in osteoblast-like cells.
Suzuki A; Ghayor C; Guicheux J; Magne D; Quillard S; Kakita A; Ono Y; Miura Y; Oiso Y; Itoh M; Caverzasio J
J Bone Miner Res; 2006 May; 21(5):674-83. PubMed ID: 16734382
[TBL] [Abstract][Full Text] [Related]
23. Histone deacetylase inhibitors promote osteoblast maturation.
Schroeder TM; Westendorf JJ
J Bone Miner Res; 2005 Dec; 20(12):2254-63. PubMed ID: 16294278
[TBL] [Abstract][Full Text] [Related]
24. Tunicamycin negatively regulates BMP2-induced osteoblast differentiation through CREBH expression in MC3T3E1 cells.
Jang WG; Kim EJ; Koh JT
BMB Rep; 2011 Nov; 44(11):735-40. PubMed ID: 22118540
[TBL] [Abstract][Full Text] [Related]
25. L51P - A BMP2 variant with osteoinductive activity via inhibition of Noggin.
Albers CE; Hofstetter W; Sebald HJ; Sebald W; Siebenrock KA; Klenke FM
Bone; 2012 Sep; 51(3):401-6. PubMed ID: 22750402
[TBL] [Abstract][Full Text] [Related]
26. Enhanced bioactivity of bone morphogenetic protein-2 with low dose of 2-N, 6-O-sulfated chitosan in vitro and in vivo.
Zhou H; Qian J; Wang J; Yao W; Liu C; Chen J; Cao X
Biomaterials; 2009 Mar; 30(9):1715-24. PubMed ID: 19131102
[TBL] [Abstract][Full Text] [Related]
27. Isolation and characterization of a mesenchymal cell line that differentiates into osteoblasts in response to BMP-2 from calvariae of GFP transgenic mice.
Kadowaki A; Tsukazaki T; Hirata K; Shibata Y; Okubo Y; Bessho K; Komori T; Yoshida N; Yamaguchi A
Bone; 2004 Jun; 34(6):993-1003. PubMed ID: 15193545
[TBL] [Abstract][Full Text] [Related]
28. Bone morphogenetic protein 2 and dexamethasone synergistically increase alkaline phosphatase levels through JAK/STAT signaling in C3H10T1/2 cells.
Mikami Y; Asano M; Honda MJ; Takagi M
J Cell Physiol; 2010 Apr; 223(1):123-33. PubMed ID: 20039267
[TBL] [Abstract][Full Text] [Related]
29. Differentiation-inducing factor-1 alters canonical Wnt signaling and suppresses alkaline phosphatase expression in osteoblast-like cell lines.
Matsuzaki E; Takahashi-Yanaga F; Miwa Y; Hirata M; Watanabe Y; Sato N; Morimoto S; Hirofuji T; Maeda K; Sasaguri T
J Bone Miner Res; 2006 Aug; 21(8):1307-16. PubMed ID: 16869729
[TBL] [Abstract][Full Text] [Related]
30. Long-term and sustained COMP-Ang1 induces long-lasting vascular enlargement and enhanced blood flow.
Cho CH; Kim KE; Byun J; Jang HS; Kim DK; Baluk P; Baffert F; Lee GM; Mochizuki N; Kim J; Jeon BH; McDonald DM; Koh GY
Circ Res; 2005 Jul; 97(1):86-94. PubMed ID: 15961719
[TBL] [Abstract][Full Text] [Related]
31. Regulation of Notch signaling genes during BMP2-induced differentiation of osteoblast precursor cells.
de Jong DS; Steegenga WT; Hendriks JM; van Zoelen EJ; Olijve W; Dechering KJ
Biochem Biophys Res Commun; 2004 Jul; 320(1):100-7. PubMed ID: 15207708
[TBL] [Abstract][Full Text] [Related]
32. Endogenous TNFalpha lowers maximum peak bone mass and inhibits osteoblastic Smad activation through NF-kappaB.
Li Y; Li A; Strait K; Zhang H; Nanes MS; Weitzmann MN
J Bone Miner Res; 2007 May; 22(5):646-55. PubMed ID: 17266397
[TBL] [Abstract][Full Text] [Related]
33. Heparin inhibits BMP-2 osteogenic bioactivity by binding to both BMP-2 and BMP receptor.
Kanzaki S; Takahashi T; Kanno T; Ariyoshi W; Shinmyouzu K; Tujisawa T; Nishihara T
J Cell Physiol; 2008 Sep; 216(3):844-50. PubMed ID: 18449905
[TBL] [Abstract][Full Text] [Related]
34. Angiopoietin-1/Tie2 signaling pathway inhibits lipopolysaccharide-induced activation of RAW264.7 macrophage cells.
Gu H; Cui M; Bai Y; Chen F; Ma K; Zhou C; Guo L
Biochem Biophys Res Commun; 2010 Feb; 392(2):178-82. PubMed ID: 20060382
[TBL] [Abstract][Full Text] [Related]
35. Priming with angiopoietin-1 augments the vasculogenic potential of the peripheral blood stem cells mobilized with granulocyte colony-stimulating factor through a novel Tie2/Ets-1 pathway.
Kim MS; Lee CS; Hur J; Cho HJ; Jun SI; Kim TY; Lee SW; Suh JW; Park KW; Lee HY; Kang HJ; Lee DS; Koh GY; Nakagami H; Morishita R; Park YB; Kim HS
Circulation; 2009 Dec; 120(22):2240-50. PubMed ID: 19917886
[TBL] [Abstract][Full Text] [Related]
36. Gene-mediated osteogenic differentiation of stem cells by bone morphogenetic proteins-2 or -6.
Zachos TA; Shields KM; Bertone AL
J Orthop Res; 2006 Jun; 24(6):1279-91. PubMed ID: 16649180
[TBL] [Abstract][Full Text] [Related]
37. Osteoclast inhibitory lectin (OCIL) inhibits osteoblast differentiation and function in vitro.
Nakamura A; Ly C; Cipetić M; Sims NA; Vieusseux J; Kartsogiannis V; Bouralexis S; Saleh H; Zhou H; Price JT; Martin TJ; Ng KW; Gillespie MT; Quinn JM
Bone; 2007 Feb; 40(2):305-15. PubMed ID: 17049328
[TBL] [Abstract][Full Text] [Related]
38. Osthole-mediated cell differentiation through bone morphogenetic protein-2/p38 and extracellular signal-regulated kinase 1/2 pathway in human osteoblast cells.
Kuo PL; Hsu YL; Chang CH; Chang JK
J Pharmacol Exp Ther; 2005 Sep; 314(3):1290-9. PubMed ID: 15956019
[TBL] [Abstract][Full Text] [Related]
39. Local delivery of COMP-angiopoietin 1 accelerates new bone formation in rat calvarial defects.
Lim SS; Kook SH; Bhattarai G; Cho ES; Seo YK; Lee JC
J Biomed Mater Res A; 2015 Sep; 103(9):2942-51. PubMed ID: 25727390
[TBL] [Abstract][Full Text] [Related]
40. Biglycan modulates osteoblast differentiation and matrix mineralization.
Parisuthiman D; Mochida Y; Duarte WR; Yamauchi M
J Bone Miner Res; 2005 Oct; 20(10):1878-86. PubMed ID: 16160746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
